|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.3 BGN | -0.57% |
|
-0.57% | +1.76% |
Tchaikapharma High Quality Medicines AD reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was BGN 42.96 million compared to BGN 42.43 million a year ago. Revenue was BGN 43.68 million compared to BGN 42.56 million a year ago.
Net income was BGN 2.9 million compared to BGN 1.4 million a year ago. Basic earnings per share from continuing operations was BGN 0.0285 compared to BGN 0.019 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.76% | 839M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
TCHAIKAPHARMA HIGH QUALITY MEDICINES AD 
